KLRN SciTech Now
Sept. 9, 2016 | Lab innovates to fight cancer
Season 1 Episode 131 | 26m 46sVideo has Closed Captions
San Antonio bio lab conducting research on compounds to help fight cancer
Cancer is a monstrous disease. Imagine if one drug could change the way cancer is treated. This week, we visited the Center for Innovative Drug Discovery (CIDD), where research is being conducted on numerous drug compounds to be used in cancer studies. We sat down with Director Dr. Stanton F. McHardy, who spoke about the innovative research projects happening inside his lab.
Problems playing video? | Closed Captioning Feedback
Problems playing video? | Closed Captioning Feedback
KLRN SciTech Now is a local public television program presented by KLRN
Support provided by viewers like you and the 80/20 Foundation.
KLRN SciTech Now
Sept. 9, 2016 | Lab innovates to fight cancer
Season 1 Episode 131 | 26m 46sVideo has Closed Captions
Cancer is a monstrous disease. Imagine if one drug could change the way cancer is treated. This week, we visited the Center for Innovative Drug Discovery (CIDD), where research is being conducted on numerous drug compounds to be used in cancer studies. We sat down with Director Dr. Stanton F. McHardy, who spoke about the innovative research projects happening inside his lab.
Problems playing video? | Closed Captioning Feedback
How to Watch KLRN SciTech Now
KLRN SciTech Now is available to stream on pbs.org and the free PBS App, available on iPhone, Apple TV, Android TV, Android smartphones, Amazon Fire TV, Amazon Fire Tablet, Roku, Samsung Smart TV, and Vizio.
Providing Support for PBS.org
Learn Moreabout PBS online sponsorship
- Science and Nature

Explore scientific discoveries on television's most acclaimed science documentary series.

- Science and Nature

Capturing the splendor of the natural world, from the African plains to the Antarctic ice.












Support for PBS provided by:
KLRN SciTech Now is a local public television program presented by KLRN
Support provided by viewers like you and the 80/20 Foundation.